Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL

NCT00300365 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome

Interventions

DRUG: Pioglitazone
OTHER: Placebo
DRUG: Niacin ER
DRUG: Aspirin

Sponsor

University of Pennsylvania

Collaborators

[object Object]